Cardlytics Q3 revenue $67.1M beats high end of guide; net loss $145.2M; Q4 outlook soft

Cardlytics, Inc.

2024-Q3 EPS reported -$3.66 revenue$204,301,000

Revenue $67.1M, down 15% YoY (13% ex Entertainment); beat high end of guidance.
Net loss $(145.2)M or $(2.90)/diluted share vs $(24.0)M loss a year ago; adjusted net loss $(0.15)/share.
Adjusted EBITDA loss $(1.8)M vs gain $3.9M in Q3 2023; billings $112.0M, down 4% YoY.
MAUs 166.4M (+2% YoY); ARPU $0.40 vs $0.49 in prior year quarter.
Q4 2024 guidance: billings $102-108M, revenue $62-67M, adjusted EBITDA loss $(5)-$(1)M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.